InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,723.20
(
0.00%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.10
(
-0.13%
)
Bitcoin
61,869.39
(
-1.66%
)
Post# of 3834
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

gss2003

Send PM Follow Ignore
Followers 2
Posts 353
Boards Moderated 0
Alias Born 07/13/2007

gss2003

Re: rickyricks post# 2544

Thursday, 10/13/2016 8:53:07 AM

Thursday, October 13, 2016 8:53:07 AM

Post# of 3834
Agreed, they don't have very good info on dosage levels and frequency it seems. They have some limited references from Phase I and maybe GR-MD-02 works, but just not in the structure on the FX trial.

Not sure if they are, but finding a partner to explore this further and for other fibrosis indications seems like it would make sense.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GALT News
More GALT News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!